Novel anti-cancer mechanism of the targeting of the association between receptor-type sodium pump and VSOR channels
Project/Area Number |
26460291
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
General physiology
|
Research Institution | University of Toyama |
Principal Investigator |
FUJII Takuto 富山大学, 大学院医学薬学研究部(薬学), 助教 (50567980)
|
Project Period (FY) |
2014-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2014: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Keywords | 癌 / ナトリウムポンプ / 生理学 / 細胞・組織 / イオンチャネル / Na,K-ATPase / 容積感受性外向き整流性アニオンチャネル / 膜マイクロドメイン / 活性酸素種 |
Outline of Final Research Achievements |
Cardiac glycosides, specific Na,K-ATPase inhibitors, has been suggested to be a valuable anti-cancer drugs. However, the molecular mechanisms for anti-cancer effects of the drugs has not been fully understood. In this study, we have clarified that non-pumping (receptor type) Na,K-ATPase is functionally coupled with volume-sensitive outwardly rectifying (VSOR) anion channels in membrane microdomains of human cancer cells. Submicromolar ouabain activates the cancer cells-specific crosstalk between Na,K-ATPase and VSOR channels in membrane microdomains mediated by NADPH oxidase-dependent reactive oxygen species generation. The activation of VSOR channels elicits anti-proliferative effects in cancer cells.
|
Report
(4 results)
Research Products
(46 results)